Drug Substance Freezing Technologies: How to Improve Your Freeze/Thaw Process

Course Overview

For the pharma and biopharma industries, the freeze/thaw process of drug substances is critical. Companies are continually looking to improve this process to protect quality, increase yield, and reduce manufacturing footprint. A lack of updated freezer technology has been a hindrance for many companies in achieving these goals.

Traditional ultra-low temperature (ULT) freezers are not designed for freezing of bulk drug substance, leading to slow freezing rates and reliability issues. Plate freezers on the other hand, are complex and expensive.

During this exclusive webinar with Jeffrey Johnson, distinguished process engineering expert, we will provide insights into the challenges faced by the industry, cover an in-depth technical evaluation of heat transfer rates, freezing capacity, and freeze/thaw data, and present an improved way to freeze that provides a reliable and efficient solution.

By watching this webinar, you will be equipped with the knowledge to enhance your freeze/thaw processes significantly, helping you to stay at the forefront of advancements in pharmaceutical manufacturing.

About the Webinar Partner, FARRAR | Trane Technologies:

FARRAR™, powered by global climate innovator, Trane Technologies, focuses on meeting the rapidly growing demand for low and ultra-low-temperature processes involved in the manufacturing, freezing and storage of medicines, vaccines, and other life-science products.